Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Jun 14, 2008; 14(22): 3554-3562
Published online Jun 14, 2008. doi: 10.3748/wjg.14.3554
Published online Jun 14, 2008. doi: 10.3748/wjg.14.3554
Groups | Before treatment | After treatment | ||||||
3 d | 7 d | IR | 10 d | IR | 14 d | IR | ||
NS | 0.11 ± 0.03 | 0.19 ± 0.05 | 0.33 ± 0.10 | 0.62 ± 0.28 | 0.80 ± 0.23 | |||
5-Fu | 0.12 ± 0.03 | 0.12 ± 0.04 | 0.24 ± 0.11 | 27.76% | 0.31 ± 0.19 | 50.27% | 0.33 ± 0.20 | 58.69% |
CTS-Pasp | 0.12 ± 0.03 | 0.19 ± 0.04 | 0.32 ± 0.10 | 2.80% | 0.54 ± 0.10 | 13.49% | 0.76 ± 0.26 | 5.58% |
CTS-Pasp-5Fu | 0.10 ± 0.01 | 0.11 ±0.04 | 0.13 ± 0.05 | 60.76% | 0.19 ± 0.05 | 68.99% | 0.23 ± 0.07 | 70.82% |
- Citation: Zhang DY, Shen XZ, Wang JY, Dong L, Zheng YL, Wu LL. Preparation of chitosan-polyaspartic acid-5-fluorouracil nanoparticles and its anti-carcinoma effect on tumor growth in nude mice. World J Gastroenterol 2008; 14(22): 3554-3562
- URL: https://www.wjgnet.com/1007-9327/full/v14/i22/3554.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.3554